EPA-0666 – Long-term maintenance of efficacy of extended-release guanfacine hydrochloride (GXR) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): double-blind, placebo-controlled, multicentre, phase 3 randomized withdrawal study

European Psychiatry - Tập 29 - Trang 1 - 2014
J. Newcorn1, V. Harpin2, M. Huss3, M. Johnson4, J.A. Ramos-Quiroga5, J. Van Stralen6, B. Dutray7, S. Sreckovic8, A. Lyne9, R. Bloomfield9, B. Robertson10
1Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA
2Ryegate Children's Centre, Sheffield, United Kingdom
3Child and Adolescent Psychiatry, Johannes Gutenberg-University Mainz, Mainz, Germany
4The Gillberg Neuropsychiatry Centre at the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
5Department of Psychiatry, Hospital Universtari Vall d’Hebron, Barcelona, Spain
6JPM van Stralen Medicine Professional Corporation, Center for Pediatric Excellence, Ottawa, Canada
7Pôle de Psychiatrie Enfant Adolescent, Centre Hospitalier de Rouffach, Rouffach, France
8Shire, Eysins, Switzerland
9Shire, Basingstoke, United Kingdom
10Shire, Wayne, USA

Thông tin
Thông tin xuất bản

European Psychiatry

Tập 29

1

Thông tin tác giả